A Clinical Trial To Evaluate The Action OF Duralabhadi Decoction In The Management Of Urinary Tract Infections.
Phase 2
- Conditions
- Health Condition 1: N00-N99- Diseases of the genitourinary systemHealth Condition 2: N30-N39- Other diseases of the urinary system
- Registration Number
- CTRI/2023/07/055121
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Subjects of either gender between age group 20-60 yrs 2)Subjects diagnosed with pus cell / bacteria in urine routine examination
3)Subjects diagnosed on basis of diagnostic parameters 4)Subjects willing to sign the consent form and agreeing to follow the protocol of the study
Exclusion Criteria
1)Subjects with known case of impaired renal function
2)Subjects with known case of malignancy or tuberculosis of urinary tract
3)Subjects with known case of Diabetes Mellitus
4)Subjects with known case of Urolithiasis
5)Women those who are pregnant and breast feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective parameters like <br/ ><br>Dysuria <br/ ><br>Increased frequency of micturition <br/ ><br>Urgency of micturition <br/ ><br>Supra pubic discomfort <br/ ><br>Fever <br/ ><br>Timepoint: Objective parameters like <br/ ><br>Urine routine examination assessed on 0th day, 6th day, 11th day, 16th day & 31st <br/ ><br>urine culture is done on 0th day, 16th day and 31st
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI